Corpus 1,272 assessed · 1,173 scored · 643 reproduced ≥75 · 168 flagged ·∅ 74.1/100
← New search

A comparative study of techniques for differential expression analysis on RNA-Seq data.

PLoS One · 2014
L1 58/100 3/4
Why this verdict

The main results reproduced, with only marginal, non-material deviations.

Reproduced on the brainbox compute brainarbeit.com
Scoring basis — itemised

Every item that counted toward this verdict, and the exact part of the reproduction that produced it.

Supporting (toward a concern)
Content-critical question only partially held
+2 pts
From: Q5 · Derivability / plausibility 🟡
Content-critical question only partially held
+2 pts
From: Q7 · Core claim 🟡
Content-critical question only partially held
+2 pts
From: Q8 · Severity of the miss (overall human judgment) 🟡
Minor / cosmetic deviation
+1 pts
From: Q3 · Location of the main deviation 🟡
Minor / cosmetic deviation
+1 pts
From: Q6 · Severity of the deviation 🟡
Input / endpoint not comparable 1:1
+1 pts
From: Q2 · Endpoint comparability 🔴
Concordant (toward reproduced)
Code + data deposited & functional
-2 pts
From: Data & code availability Available & functional
Total score +7
✓ What held up
  • Same input data as the authors
What did not (or only partly)
  • 🔴Reported values were only indirectly comparable
  • 🟡A deviation arose in the data or preprocessing
  • 🔴A deviation was attributed to the published material
  • 🟡Reported values were not (fully) derivable from the shared data
  • 🟡The deviation was non-trivial in magnitude
  • 🟡The central claim did not (fully) hold under reproduction
  • 🟡Overall, the reproduction showed a material discrepancy
How its reproducibility compares
58/100
Reproducibility score
0.9 SD below mean
vs. all fields · 1173 studies
🎯 Scores higher than 18% of all assessed papers rank 950 of 1173 scored

A 0–100 reproducibility-quality score from the per-question grades, shown as a z-score: standard deviations above (+) or below (−) the mean of comparable assessments.

Reproduction agent’s raw note

Reproduced the core DE pipeline (TopHat -> HTseq-count -> DESeq/edgeR, plus TopHat -> Cuffdiff2) of Zhang et al. 2014 (PMID 25119138) on the paper's assigned no-replicate MAQC dataset (GSE24284/GSE24283, GSM597210 HBR + GSM597211 UHR, 'Wu' technical replicate). Raw read counts exactly match the paper's own supplementary Table S1 (53,238,798 hbr / 59,461,348 uhr), validating correct dataset selection. TopHat alignment (79.9%/82.2% mapping rates), htseq-count (cross-validated against TopHat's multi-mapping counts), DESeq (blind/fit-only/local dispersion, 0 genes padj<0.05, reflecting the method's known conservatism without replicates), and edgeR (fixed BCV=0.4 per the paper's stated value, 4,317/63,677 genes FDR<0.05) all completed successfully. Cuffdiff2 on pooled BAMs found 193/63,652 genes significant (q<0.05). Benchmarked all three methods against a TaqMan qRT-PCR gold standard (596 genes, sourced via the bioconductor-seqc package as a documented substitute for raw GSE5350 files) using AUC1 (full ROC) and AUC2 (FPR<=0.05 restricted ROC, the paper's own definitions, independently confirmed against its supplementary Table S4): AUC1 = 0.95/0.92/0.92 and AUC2 = 0.59/0.61/0.59 for DESeq/edgeR/Cuffdiff2 respectively. This reproduces the paper's qualitative finding that edgeR performs comparatively best at the restricted, decision-relevant FPR range, though DESeq narrowly leads on full-ROC AUC1 in our run. Exact published MAQC-specific AUC1/AUC2 numbers were not extractable from the paper's text, figures-as-images, or its five supplementary tables (S1-S5, all individually checked), so several quantitative claims are graded 'partial' rather than 'exact' pending human reviewer access to Figure 2/Figure 7 source data. No drops; all assigned pipeline components were run to completion on real data.

💻 Code ↗ 🗄 Data: GSE24284

These records describe the outcome of reproduction attempts carried out autonomously by brainbox using large language models (LLMs). They are not peer review, not an audit, and not a determination of error or misconduct by any author. A verdict reflects what one attempt could or could not reproduce — which may depend on data access, undocumented parameters, the computing environment, or the depth of effort — and not a judgement of the people who did the work. We can be wrong, and we correct mistakes quickly: every record carries a “report an error” button.

✎ I am an author of this paper

Updated or fixed a deposit, or is there an erratum? Ask us to re-run the metrics. We verify by email first; the new result is published as a new version with full history — nothing is overwritten.

Reason for the rerun

We email you a confirmation link first. The rerun is an objective re-measurement — it cannot change the verdict in your favour, only ask us to look again.

Provenance — full disclosure

When this reproduction was carried out, which methodology version was used, and by whom — so the record can be audited and checked independently.

Reproduced
2026-08-02
Rubric version
v1.0
Assessed by
🤖 AI curator · claude (ai-curator room) · v1.0 · run #1 2026-08-02
no human curator yet
Last updated
2026-08-02

Provisional, curator- or AI-assessed, and independently checkable. A reproduction outcome states what one attempt could reproduce — not a judgement of the authors.

Deep full-text extraction

Model: opus
Founding hypothesis

There is no consensus on which software tool is optimal for detecting differentially expressed genes from RNA-Seq data, nor on how to design an efficient RNA-Seq experiment. This study asks how Cufflinks-Cuffdiff2, DESeq and edgeR perform for differential expression analysis when the number of biological replicates, sequencing depth, and balanced vs. unbalanced sequencing depth within and between groups are varied.

Core claims
  • edgeR performs slightly better than DESeq and Cuffdiff2 in terms of the ability to uncover true positives. finding
  • DESeq, or taking the intersection of DEGs from two or more tools, is recommended when the number of false positives is a major concern. finding
  • edgeR is slightly preferable for differential expression analysis in other circumstances, at the expense of potentially introducing more false positives. finding
  • Cufflinks-Cuffdiff2, which takes BAM files rather than count matrices as input, had been omitted from previous comparison studies; this study includes it alongside the count-matrix-based DESeq and edgeR. method
  • Performance is benchmarked against sets of DEGs identified independently by quantitative RT-PCR (MAQC data) or by microarray (mouse neurosphere data). method
  • The Poisson distribution underestimates variation when biological replicates are included (overdispersion), so the negative binomial distribution, with a scaling factor for the variance, has achieved a dominant position for modelling RNA-Seq feature counts. mechanism
  • A new in-house mouse neurosphere RNA-Seq dataset (K_N, KCl vs. norepinephrine) plus matched microarray data are released as a benchmarking resource (NCBI SRA SRX516577; GEO GSE57440). resource
  • Analysis pipelines and custom PERL scripts for subsampling datasets and generating BAM files from simulated count values are publicly available at https://github.com/Qiongyi/RNA-Seq-comparison/. resource
Experimental setups
Assay System Perturbation Readout Platform
Single-end RNA-Seq (MAQC dataset I and II) Human brain reference RNA (hbr) and universal human reference RNA (uhr) biological samples; no biological replicates none (hbr vs. uhr sample comparison) Mapped read counts per gene / differentially expressed genes between hbr and uhr Illumina GAII (35 bp reads, Dudoit lab; 50 bp reads, Wu lab)
Paired-end RNA-Seq (K_N dataset) Primary neurospheres from hippocampal tissue of adult (8–12 week) male C57BL/6J mice, cultured in complete neurosphere medium with EGF and bFGF; 4 biological replicates per group Drug/ion treatment: norepinephrine (10 µM) vs. potassium chloride (15 mM), neurospheres collected on day 14 Mapped read counts per gene / DEGs between K and N groups Illumina HiSeq2000; Illumina TruSeq RNA Sample Preparation Kit v2 (cat#RS-122-2001); TRIzol Reagent; Ambion DNA-free kit; QuBit RNA assay kit (Q32852); Agilent RNA 6000 Pico Kit on Agilent 2100 Bioanalyser (RIN>8)
RNA-Seq (LCL1 dataset, real data used for false positive rate estimation) Lymphoblastoid cell lines from Yoruban individuals (HapMap); 40 samples with >8 M reads sequenced at Yale, out of 69 cell lines none (samples randomly assigned to two hypothetical treatment groups of N = 20, 14, 8, 6, 5, 4, 3, 2, 1) Number of DEGs called / false positive rate, averaged over 10 independent simulations Illumina GAII
Simulated RNA-Seq (LCL2 dataset) In silico simulation based on the LCL1 lymphoblastoid cell line dataset; BAM files generated by randomly adding/removing aligned reads with custom PERL scripts and SAMtools DEGs simulated in a random 10% of total genes; counts scaled by exp{(−1)^i δ_j}, δ_j from a two-component normal distribution True positive rate and false positive rate against known DEG/non-DEG sets, averaged over 10 simulations
Subsampled RNA-Seq depth/balance experiments (K_N subsets and LCL3 dataset) Subsets of K_N_full (K_N_30M, 20M, 10M, 5M; unbalanced between groups 1 and 2) and of LCL2 (S1_8M_balanced, S2_5M_balanced, S3_1M_balanced, S4_5M_1M_btw, S5_5M_1M_within) Varying sequencing depth; unbalanced sequencing depth between and within groups Number of DEGs, TPR, FPR, AUC1 (0≤FPR≤1) and AUC2 (0≤FPR≤0.05) per tool
Quantitative RT-PCR (benchmark/gold standard) MAQC uhr and human brain samples, four technical replicates each (GEO GSE5350, GSM129638–GSM129645) none log2 fold change between hbr and uhr; positive set |log2FC|>2, negative set |log2FC|<0.2
cDNA microarray (benchmark) Mouse neurospheres grown with norepinephrine or KCl, n = 3 each (two biological replicates in common with the RNA-Seq data) Norepinephrine (N) vs. potassium chloride (K) treatment log2 fold change and P-value; positive set |log2FC|>1 and P<0.05, negative set |log2FC|<0.1 and P>0.1 Affymetrix GeneChip Mouse Gene 1.0 ST arrays, Affymetrix GeneChip Scanner; Applause WT-Amp ST kit (NuGEN), Encore Biotin module (NuGEN); Partek Genomics Suite
Read alignment and count quantification pipeline Human reference genome hg19 (MAQC, LCL) and mouse genome mm10 (K_N) none Aligned BAM files for Cuffdiff2 and raw count tables for DESeq/edgeR; DEG lists; AUC of ROC curves Tophat v2.0.8; HTseq-count v0.5.4p2; Cufflinks-Cuffdiff2 v2.1.1; DESeq v1.10.1; edgeR v3.0.8 (Bioconductor 2.12, R 2.15.1)
Key results
  • edgeR uncovers more true positives than DESeq and Cuffdiff2
  • edgeR's higher sensitivity comes at the expense of potentially introducing more false positives, so DESeq or the intersection of two or more tools is preferred when false positives are a major concern
  • MAQC dataset I contains 137.77 M single-end 35 bp reads and dataset II contains 112.70 M single-end 50 bp reads, both without biological replicates 137.77 M and 112.70 M reads
  • The in-house K_N dataset yielded 476.38 M paired-end 101 bp x2 reads across 4 biological replicates per group 476.38 M reads (231.55 M K, 244.83 M N)
  • qRT-PCR benchmark yielded 410 genes in the positive set and 86 genes in the negative set out of 1044 genes 410 positive / 86 negative of 1044
  • Microarray benchmark yielded 77 genes in the positive set and 9072 genes in the negative set out of 35557 genes 77 positive / 9072 negative of 35557
  • No differentially expressed genes are expected between the two hypothetical LCL1 groups because samples were randomly drawn from the same population, allowing false positive rate estimation
  • Performance was quantified by AUC1 (area under the ROC over 0≤FPR≤1, maximum 1) reflecting overall DEG identification and AUC2 (0≤FPR≤0.05, maximum 0.05) reflecting performance in the discovery-relevant FPR range AUC1 max = 1; AUC2 max = 0.05
Key statistics
  • count 137.77 million RNA-Seq reads (read length 35 bp) (MAQC dataset I, Dudoit group, Illumina GAII)
  • count 112.70 million RNA-Seq reads (read length 50 bp) (MAQC dataset II, Wu group, Illumina GAII)
  • count 476.38 M paired-end reads (231.55 M for K, 244.83 M for N) (K_N_full mouse neurosphere dataset, 4 biological replicates per group)
  • count 410 genes in the positive set and 86 genes in the negative set among 1044 genes (qRT-PCR benchmark; positive |log2FC|>2, negative |log2FC|<0.2)
  • count 77 genes in the positive set and 9072 genes in the negative set among 35557 genes (K_N microarray benchmark; positive |log2FC|>1 and P<0.05, negative |log2FC|<0.1 and P>0.1)
  • count 40 samples selected (>8 M reads each) from 69 sequenced Yoruban cell lines (LCL1 dataset used for false positive rate estimation)
  • other 10% of total genes simulated as DEGs; counts scaled by exp{(−1)^i δ_j}, δ_j ~ two-component normal with μ = (−0.5, 0.5) and σ = (0.7, 0.7) (LCL2 simulation design)
  • count 10 independent simulations, averaged for number of DEGs, FPR and TPR (LCL1, LCL2 and LCL3 analyses)

Statistical methods review

Model: sonnet

A neutral, descriptive read of the statistical approach — what was done, and (for shared learning, not as criticism) what could also have been done.

This is a methods-comparison paper that benchmarks three RNA-Seq differential expression (DE) analysis tools (Cuffdiff2, DESeq, edgeR) using both real datasets (MAQC, an in-house K_N mouse neurosphere dataset, and a Yoruban lymphoblastoid cell line population dataset) and simulated data with known ground-truth DEGs. Each tool's built-in statistical model (beta negative binomial for Cuffdiff2; negative binomial with local regression for DESeq; negative binomial with empirical Bayes dispersion moderation for edgeR) was used to call DEGs, and performance was evaluated against qRT-PCR- and microarray-derived positive/negative gene sets using ROC curves and area-under-curve (AUC1 full range, AUC2 restricted to FPR≤0.05) rather than a single hypothesis test. Simulation-based results (LCL2/LCL3) were averaged over 10 independent simulation runs, and effects of replicate number, sequencing depth, and balanced vs. unbalanced depth were assessed via true/false positive rates.

Replicationmixed Sample sizeVaries by dataset: MAQC used technical replicates only (no biological replicates); K_N used 4 biological replicates per treatment group, with subsampled depth subsets; LCL1 used hypothetical groups of N=20,14,8,6,5,4,3,2,1 biological replicates randomly assigned from 40 individuals; simulation-based LCL2/LCL3 results were averaged over 10 independent simulations Groupshbr vs. uhr (MAQC); K (potassium) vs. N (norepinephrine) treated neurosphere cells; randomly split hypothetical groups from the same population (LCL) Pairingunpaired Randomization/blindingnot stated for the biological experiments; random assignment of samples to hypothetical groups is described for the LCL simulation analysis Dispersionunclear Effect sizesyes
Statistical tests used
Test Applied to n Assumptions
Negative binomial Wald/likelihood-based DE test (DESeq) DEG calling for MAQC, K_N, and LCL datasets varies by dataset (e.g., 0 biological replicates for MAQC technical data; 4 biological replicates for K_N; 1-20 hypothetical replicates for LCL1) not stated
Negative binomial DE test with empirical Bayes dispersion moderation (edgeR) DEG calling for MAQC, K_N, and LCL datasets varies by dataset (see above) not stated
Beta negative binomial model-based DE test (Cuffdiff2) DEG calling for MAQC, K_N, and LCL datasets varies by dataset (see above) not stated
ROC/AUC (AUC1 full range, AUC2 restricted to FPR≤0.05) Comparing each tool's DEG calls to qRT-PCR (MAQC) or microarray (K_N) gold-standard positive/negative gene sets 410 positive / 86 negative genes (qRT-PCR benchmark); 77 positive / 9072 negative genes (microarray benchmark) not stated
Fixed log2 fold-change (and, for microarray, P-value) thresholds to define positive/negative gold-standard gene sets Construction of benchmark sets from qRT-PCR and microarray data 1044 genes (qRT-PCR); 35557 genes (microarray) not stated
Approaches that could also have been used
  • Tool performance was evaluated using ROC curves and AUC computed over the full FPR range and a restricted low-FPR range (AUC2), against benchmark sets that are highly imbalanced (e.g., 77 positive vs. 9072 negative genes in the microarray benchmark).
    Could also: Precision-recall (PR) curves and area under the PR curve — PR curves are often preferred to ROC/AUC when the positive class is much rarer than the negative class, since they can be more sensitive to differences in performance on the minority (positive/DEG) class.
  • Gold-standard positive and negative gene sets were defined using hard log2 fold-change (and, for microarray, P-value) cutoffs rather than using the qRT-PCR/microarray measurements as continuous quantities.
    Could also: Rank or linear correlation (e.g., Spearman or Pearson correlation) between RNA-Seq-derived and qRT-PCR/microarray-derived fold changes across all genes — A continuous correlation-based comparison uses information from all genes rather than only those passing a threshold, and avoids sensitivity to the specific cutoff values chosen to define the positive/negative sets.
  • All three evaluated tools model RNA-Seq counts with a negative binomial (or beta negative binomial) distribution and test for differential expression directly on counts.
    Could also: A linear-model-based approach such as limma-voom, which transforms counts and associated precision weights for use in linear models with empirical Bayes moderated t-statistics — Linear-model-based approaches can be convenient for more complex experimental designs (e.g., covariates, multi-factor models) and provide moderated t/F-statistics within a familiar linear-modeling framework.
  • Simulation-based results (LCL2/LCL3 datasets) were summarized as average values (e.g., mean TPR/FPR/AUC) across 10 independent simulations.
    Could also: Reporting the spread across simulation runs (e.g., SD or a range/CI of AUC values across the 10 runs) alongside the means — Showing variability across simulation replicates would convey how consistent each tool's performance was from run to run, in addition to the average performance.
  • The number of biological replicates in the LCL1 false-positive-rate analysis was varied descriptively (N = 1 to 20) to observe how false positive rate changes with replicate number.
    Could also: A formal statistical power/sample-size analysis for RNA-Seq (e.g., using tools such as RNASeqPower or PROPER) to estimate the replicate number needed for a target power and false discovery rate — A power-analysis-based approach can translate the same underlying variance/dispersion information into a specific replicate-number recommendation for a desired detection power, complementing the descriptive replicate sweep used here.
  • Genome-wide DEG calls from DESeq, edgeR, and Cuffdiff2 were compared to benchmark sets without an explicitly stated multiple-testing correction step in the analyzed text.
    Could also: Explicitly reporting a Benjamini-Hochberg false discovery rate (FDR) threshold applied across all tested genes — Because DE analysis tests thousands of genes simultaneously, explicitly stating and reporting an FDR-controlling procedure (commonly built into DESeq/edgeR output) can make the multiple-testing handling transparent to readers comparing tools.
Software: Cufflinks/Cuffdiff2 2.1.1 · DESeq (R/Bioconductor) 1.10.1 · edgeR (R/Bioconductor) 3.0.8 · R/Bioconductor R 2.15.1 / Bioconductor 2.12 · TopHat 2.0.8 · HTSeq-count 0.5.4p2 · SAMtools · Partek Genomics Suite

What was reproduced

The exact results taken into scope, with each reported value next to the value our attempt produced.

Raw RNA-Seq read counts for MAQC hbr/uhr samples (GSE24284/GSM597210+GSM597211, 'Wu' technical replicate, 7 me …
Reported
Table S1 (Wu column): hbr=53,238,798 reads; uhr=59,461,348 reads
Reproduced
TopHat 'Input' reads after merging all 7 SRR runs per condition: hbr=53,238,798; uhr=59,461,348
exact
TopHat splice-aware alignment of merged hbr/uhr FASTQ against GRCh37/Ensembl-75 completes with plausible mappi …
Reported
Not given as an explicit numeric target in the paper text (methods only).
Reproduced
hbr: 82.2% overall mapping rate (43,783,472/53,238,798 mapped, 3,183,366 multi-mapped); uhr: 79.9% (47,491,885/59,461,348 mapped, 4,518,534 multi-mapped)
partial
DESeq no-replicate ('blind' dispersion estimation, fitType=local after default parametric fit failed to conver …
Reported
Paper describes DESeq's no-replicate blind/fit-only approach as conservative; no exact published significant-gene count found for the MAQC dataset specifically.
Reproduced
63,677 genes tested; 0 genes at padj<0.05 (lowest padj ~0.18) — consistent with the described conservative behavior of the blind method without replicates.
partial
edgeR no-replicate analysis using a fixed, literature-based BCV=0.4 for well-controlled human experiments (pap …
Reported
Paper states BCV~0.4 is used/appropriate for human MAQC data; no exact published significant-gene count found for this dataset.
Reproduced
63,677 genes tested; 4,317 genes at FDR<0.05.
partial
Cuffdiff2 run directly on pooled per-condition BAMs (no replicate structure), matching the paper's 'reads merg …
Reported
No exact published significant-gene count found for this dataset in extractable text.
Reproduced
63,652 genes tested (status=OK etc.); 193 genes significant at default q<0.05.
partial
AUC1 (full ROC, 0<=FPR<=1) and AUC2 (restricted ROC, 0<=FPR<=0.05) benchmarking of DESeq/edgeR/Cuffdiff2 again …
Reported
Paper (Figure 2, Figure 7; prose only, no extractable numeric table): 'edgeR reported to generally perform slightly better than the other two tools as judged by the two AUC statistics' across datasets. Exact MAQC-specific AUC1/AUC2 numbers exist only as plotted values inside Figure 2/Figure 7 images; not present in the article's extractable text or in supplementary Tables S1-S5 (S1=read counts, S2=mouse K_N dataset, S3=LCL3 subsampling scheme, S4=TP/FP/TN/FN definitions, S5=LCL1 FPR table — none contain MAQC AUC values).
Reproduced
Gold standard: 596 TaqMan genes (510 TP / 86 TN, >=3/4 'P' detection calls in both A and B). AUC1: DESeq=0.9535, edgeR=0.9229, Cuffdiff2=0.9233. AUC2 (FPR<=0.05): DESeq=0.5877, edgeR=0.6067, Cuffdiff2=0.5884.
partial

Assessments & scoring basis

Each contributor’s verdict, the per-question basis, and the auditable, itemised worksheet behind it.

🤖 AI curator · claude (ai-curator room) · v1.0 L1 58/100

An automated assessment. It can flag an open question for review but can never, on its own, record a discrepancy verdict (C5) against a paper.

🟢1. Data identity
🔴2. Endpoint comparability
🟡3. Location of the main deviation
🔴4. Cause of the deviation
🟡5. Derivability / plausibility
🟡6. Severity of the deviation
🟡7. Core claim
🟡8. Severity of the miss (overall human judgment)
Scoring basis — itemised

Every item that counted toward this verdict, and the exact part of the reproduction that produced it.

Supporting (toward a concern)
Content-critical question only partially held
+2 pts
From: Q5 · Derivability / plausibility 🟡
Content-critical question only partially held
+2 pts
From: Q7 · Core claim 🟡
Content-critical question only partially held
+2 pts
From: Q8 · Severity of the miss (overall human judgment) 🟡
Minor / cosmetic deviation
+1 pts
From: Q3 · Location of the main deviation 🟡
Minor / cosmetic deviation
+1 pts
From: Q6 · Severity of the deviation 🟡
Input / endpoint not comparable 1:1
+1 pts
From: Q2 · Endpoint comparability 🔴
Concordant (toward reproduced)
Code + data deposited & functional
-2 pts
From: Data & code availability Available & functional
Total score +7

Input side is exemplary: the merged 7-lane MAQC read counts (hbr=53,238,798 / uhr=59,461,348) match the paper's own Table S1 'Wu' column exactly, and htseq-count's __alignment_not_unique cross-validates against TopHat's multi-alignment counts, so dataset identity and alignment are not in question. The deviation sits at the endpoint, on the authors' reporting side: the paper publishes its MAQC AUC1/AUC2 comparison only inside Figure 2/Figure 7 images with a prose summary, and none of Tables S1-S5 carry the numbers — so our AUC1 (DESeq 0.9535 / edgeR 0.9229 / Cuffdiff2 0.9233) and AUC2 (0.5877 / 0.6067 / 0.5884) can be computed but never checked. Severity is moderate, not critical: the paper's 'edgeR slightly better' trend is reproduced on AUC2 but reversed on AUC1, within a narrow 0.92-0.95 band, and the claim was stated as pooled across three datasets. Two self-chosen steps (DESeq fitType='local' after non-convergence; TaqMan gold standard via bioconductor-seqc instead of raw GSE5350) are legitimate and documented but add reproducer-side degrees of freedom — no fabrication signal anywhere.

🤝
Reproduced automatically — and fairly

Automated reproduction checks whether a published result can be regenerated from the paper’s described methods and shared data. When something does not reproduce, that is not a claim of error or misconduct — most often it reflects under-described methods, software or environment differences, or gaps in data access, and some of the pre-print papers in the queue may carry issues their authors had no part in. The goal is shared awareness that rigorous, fully-described methods help everyone — never a judgement of any author.

Are you an author? We would genuinely like to hear from you — to clarify the record, add data or code, re-run the pipeline after an accession update, and publish your response right next to the assessment. Everything here is open and auditable.

🚩 Report an error in this record

Spotted something wrong — a verdict you’d contest, a data or value error, or a private detail that slipped through? Tell us, with a short justification. Authors and readers are equally welcome to write in; we review every report.

Prefer email, or the form below not working? Contact us at support@doesitreproduce.com.